<SEC-DOCUMENT>0001200375-23-000022.txt : 20230720
<SEC-HEADER>0001200375-23-000022.hdr.sgml : 20230720
<ACCEPTANCE-DATETIME>20230720160721
ACCESSION NUMBER:		0001200375-23-000022
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230720
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Cost Associated with Exit or Disposal Activities
ITEM INFORMATION:		Material Impairments
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230720
DATE AS OF CHANGE:		20230720

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CODEXIS, INC.
		CENTRAL INDEX KEY:			0001200375
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		IRS NUMBER:				710872999
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34705
		FILM NUMBER:		231099808

	BUSINESS ADDRESS:	
		STREET 1:		200 PENOBSCOT DRIVE
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94063
		BUSINESS PHONE:		650-421-8100

	MAIL ADDRESS:	
		STREET 1:		200 PENOBSCOT DRIVE
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94063

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CODEXIS INC
		DATE OF NAME CHANGE:	20021022
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cdxs-20230720.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:1cb7a91c-b7e6-41d3-8461-a3f2fab9c937,g:0f1071e6-ba57-401c-a5f3-a8991f751076,d:c191d621d8f241dfbc0f875820dbc5e2--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cdxs-20230720</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0001200375</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-23">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cdxs-20230720.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001200375</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-20</xbrli:startDate><xbrli:endDate>2023-07-20</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ic191d621d8f241dfbc0f875820dbc5e2_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:2pt;text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:174%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:174%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:174%">Washington, D.C. 20549 </span></div><div style="text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________</span></div><div><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:174%">&#160;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:174%">CURRENT REPORT </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:174%">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:174%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">July&#160;20, 2023</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________</span></div><div style="text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Codexis, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">(Exact name of registrant as specified in its charter) </span></div><div style="text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________</span></div><div><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:174%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.849%"><tr><td style="width:1.0%"></td><td style="width:31.681%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.681%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-34705</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">71-0872999</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:174%">(State or other jurisdiction</span></div><div style="margin-bottom:0.5pt;text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:174%">of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:174%">(Commission</span></div><div style="margin-bottom:0.5pt;text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:174%">File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:174%">(I.R.S. Employer</span></div><div style="margin-bottom:0.5pt;text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:174%">Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">200 Penobscot Drive</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Redwood City</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-9">CA</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">94063</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:174%">(Address of Principal Executive Offices) (Zip Code) </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%"> Registrant's telephone number, including area code  </span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">650</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">421-8100</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Not Applicable </span></div><div style="text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:174%">(Former name or former address, if changed since last report) </span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:174%">&#160;</span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:174%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:174%;text-decoration:underline">see</span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:174%"> General Instruction A.2. below): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.693%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#333333;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#333333;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#333333;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#333333;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.874%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Title of Each Class</span></td><td colspan="3" style="border-left:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trading</span></td><td colspan="3" style="border-left:2pt solid #000;border-right:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-left:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Symbols(s)</span></td><td colspan="3" style="border-left:2pt solid #000;border-right:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000;border-left:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:2pt solid #000;border-left:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">CDXS</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:2pt solid #000;border-left:2pt solid #000;border-right:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="text-align:right"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:96.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.653%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange </span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Act.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-21">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="ic191d621d8f241dfbc0f875820dbc5e2_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.567%"><tr><td style="width:1.0%"></td><td style="width:10.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;2.02</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operations and Financial Condition.</span></td></tr></table></div><div style="padding-left:18pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 20, 2023 Codexis, Inc. (the &#8220;Company&#8221;) announced certain of its preliminary unaudited financial results for the quarter ended June 30, 2023, reiterated and provided new financial guidance, and provided an overview of certain updates in connection with its ongoing strategy to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">focus resources on programs with the strongest commercial opportunity and greatest probability of near-term success</span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div><span><br/></span></div><div style="padding-left:18pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The information contained in Item 2.02 of this Current Report (including Exhibit 99.1 attached hereto) shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 2.05 Costs Associated with Exit or Disposal Activities.</span></div><div><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 20, 2023, in alignment with its enhanced strategic focus, the Company publicly announced and informed its employees that it was implementing a workforce reduction of approximately 25%. This measure was implemented in support of the Company&#8217;s organizational streamlining to focus on the continued advancement and commercialization of its Enzyme-Catalyzed Oligonucleotide (ECO) Synthesis&#8482; platform and its highly complementary Pharmaceutical Manufacturing business. </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company expects the payment of post-employment benefits to impacted employees, as well as the payment of other expenses such as related tax costs, will result in the Company recording an expense of approximately $2.9 million. The Company anticipates this expense will be recognized in the third quarter of 2023 and paid primarily during the same period. The Company expects the workforce reduction to be substantially completed by September 30, 2023.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The charges that the Company expects to incur are subject to a number of assumptions, including legal requirements in applicable jurisdictions, and actual expenses may differ materially from the estimates disclosed above. </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, as part of this enhanced strategic focus, the Company is also streamlining operations by discontinuing investment in certain development programs, primarily in Biotherapeutics, and consolidating operations to its headquarters which may result in write-downs of assets and additional charges. The Company is currently not able to provide an estimate of the timing or the amount, if any, of these potential write-downs and charges it may incur. The Company will file an amendment to this Current Report on Form 8-K, as necessary, if and when such amounts become estimable.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 2.06 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Material Impairments.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The information set forth under Item 2.05 of this Current Report on Form 8-K is incorporated herein by reference. </span></div><div><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Forward-Looking Statements</span></div><div><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Current Report on Form 8-K contains &#8220;forward-looking&#8221; statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are based on management&#8217;s beliefs and assumptions and on information currently available to management. Forward-looking statements include, but are not limited to, statements regarding the intended benefits of the Company&#8217;s refined corporate strategy; the number of employees impacted by the reduction in force; and the Company&#8217;s expectations regarding the timing of such costs and the timing of completion of the reduction in force. Undue reliance should not be placed on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond the Company&#8217;s control and that could materially affect actual results. Information about factors that could materially affect actual results can be found in the Company&#8217;s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on May 4, 2023, including under the caption &#8220;Risk Factors,&#8221; and in the Company&#8217;s other periodic reports filed with the SEC. The Company expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.567%"><tr><td style="width:1.0%"></td><td style="width:10.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;9.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statement and Exhibits.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d) </span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibits.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:9.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.214%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a991pressreleasejuly202023.htm">Press release dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a991pressreleasejuly202023.htm">July </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a991pressreleasejuly202023.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a991pressreleasejuly202023.htm">0</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a991pressreleasejuly202023.htm">, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a991pressreleasejuly202023.htm">23.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)</span></td></tr></table></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="ic191d621d8f241dfbc0f875820dbc5e2_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE </span></div><div style="margin-bottom:8pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div style="margin-bottom:8pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: July&#160;20, 2023 </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"></td><td style="width:47.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.722%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CODEXIS, INC.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Sriram Ryali</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sriram Ryali</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief&#160;Financial Officer</span></td></tr></table></div><div style="margin-bottom:8pt;padding-left:36pt;padding-right:36pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a991pressreleasejuly202023.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iafceddb7681c4a65a9c3537fbe4d2d25_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 99.1</font></div><div style="text-align:right"><font><br></font></div><div><img alt="image.jpg" src="image.jpg" style="height:38px;margin-bottom:5pt;vertical-align:text-bottom;width:249px"></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Codexis Announces Enhanced Strategic Focus and Extends Projected Cash Runway to Mid-2026</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Organization Streamlined to Focus on Continued Advancement and Commercialization of ECO Synthesis</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8482;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"> Platform for RNAi Therapeutics Production</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Codexis Expects its Pharmaceutical Manufacturing Business to Return to Growth in 2024</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Company Reiterates 2023 Product Revenue Guidance and Announces Preliminary Unaudited Revenue for the Second Quarter of 2023</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Management to Host Conference Call Today at 4&#58;30 p.m. ET</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">REDWOOD CITY, Calif., July 20, 2023</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> -- Co</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">dexis, Inc. (NASDAQ&#58; CDXS), a leading enzyme engineering company, today announced that, in alignment with its previously announced strategy to focus resources on programs with the strongest probability of creating significant value in the near-term and beyond, the Company intends to prioritize the advancement and commercialization of its Enzyme-Catalyzed Oligonucleotide (ECO) Synthesis&#8482; platform and its highly complementary Pharmaceutical Manufacturing business. As part of this enhanced strategic focus, the Company is streamlining operations, including discontinuing investment in certain development programs, primarily in Biotherapeutics, consolidating operations to its headquarters and reducing headcount by approximately 25%. Codexis had $92.1 million in cash and cash equivalents as of June 30, 2023, and with these changes expects that this balance will be sufficient to fund its planned operations to mid-2026, providing the Company the opportunity to deliver on critical milestones related to its ECO Synthesis&#8482; platform.</font></div><div><font><br></font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8220;As a result of our disciplined portfolio streamlining, Codexis now reflects a built-to-win, focused organization with cash runway to fuel our strategic priorities through mid-2026, including the commercialization of our ECO Synthesis&#8482; platform,&#8221; said Stephen Dilly, MBBS, PhD, President and Chief Executive Officer of Codexis. &#8220;By building upon our existing strength in enzyme engineering, we believe we have identified a concentrated group of potential high-impact programs where our enzymes and expertise can drive meaningful differences for life science and pharmaceutical customers. Our ECO Synthesis&#8482; technology sits at the top of this list, given its potential to create tremendous value for Codexis and our customers by enabling commercial-scale manufacture of RNAi therapeutics, a powerful, growing class of medicines being developed to address difficult to treat diseases impacting millions of patients.&#8221; </font></div><div><font><br></font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Kevin Norrett, Chief Operating Officer of Codexis, added, &#8220;As late clinical stage RNAi therapeutic candidates advance toward approval, we believe that current phosphoramidite chemistry methods alone will be unable to sufficiently scale production to meet the coming wave of anticipated demand. We believe Codexis is uniquely positioned to design and bring to market an enzymatic solution that addresses this challenge. We expect to demonstrate gram-scale synthesis of our ECO Synthesis&#8482; technology by the end of this year, with a path toward our commercialization goal in 2025. Coupled with an anticipated return to growth of product revenues in our Pharmaceutical Manufacturing business next year, we remain confident that we are on track and well-positioned to realize significant value in the near term.&#8221;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Portfolio Updates</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font></div><div><font><br></font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">Life Sciences </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:13.8pt">Codexis will prioritize its resources to complete development and commercialization of its proprietary ECO Synthesis&#8482; platform, offering a suite of enzymes and a process designed to enable scalable production of RNA interference (RNAi) therapeutics, including small interfering RNA (siRNA). With over 450 RNAi therapies currently in clinical development, including more than 40 assets in Phase 2 and Phase 3 clinical trials targeting disease indications impacting millions of patients, demand for siRNA is projected to outpace current production capabilities in the coming years. By enabling the manufacture of these therapeutics through an enzymatic route, Codexis&#8217; ECO Synthesis&#8482; technology is specifically engineered to address the challenges with scalability and sustainability associated with traditional phosphoramidite chemistry methods. Codexis anticipates demonstrating gram-scale synthesis of the platform by the end of 2023, providing a key point of technical validation to enable select pre-commercial customer testing of the platform to begin in 2024. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:13.8pt">The Company expects to make its double-stranded RNA (dsRNA) ligase available to customers in 2024. As Codexis&#8217; market entry point in RNAi therapeutics production, the dsRNA ligase integrates with existing phosphoramidite chemistries to stitch together small, manufactured strands of RNA. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:13.8pt">The Company plans to focus on a select group of highly differentiated enzymes engineered to address complex, unmet needs for life science customers. This includes Codexis&#8217; newly engineered DNA ligase, designed to improve ligation efficiency and potentially allow for increased sensitivity and more accurate detection in oncology applications, and the Codex</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:107%">&#174;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%"> HiCap RNA polymerase, which reduces unwanted double-stranded RNA contamination and increases mRNA capping efficiency. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:13.8pt">The Company is actively exploring options to drive value by potentially monetizing other assets within its Life Sciences portfolio. </font></div><div><font><br></font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:107%">Pharmaceutical Manufacturing</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:13.8pt">Codexis has a long history of engineering increasingly complex biocatalysts for large pharmaceutical customers, many of which are now advancing pipelines of RNAi therapeutic candidates. As a result, the technology, infrastructure and commercial reach of the Company&#8217;s Pharmaceutical Manufacturing business is highly complementary to the ECO Synthesis&#8482; platform. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:13.8pt">Codexis will continue to collaborate with customers on Pharmaceutical Manufacturing projects and expects a return to growth of this business in 2024. </font></div><div><font><br></font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:107%">Biotherapeutics </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:13.8pt">The Company will discontinue all pre-clinical discovery work in Biotherapeutics, including inborn errors of metabolism and gene therapy. This decision reflects Codexis&#8217; strategic focus on the most valuable applications of its CodeEvolver&#174; directed evolution platform and the prioritization of opportunities that have the potential to generate revenue in the next two to five years.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:13.8pt">Codexis is planning to discontinue its 50&#47;50 development support of CDX-7108 and is in active negotiations with its partner, Nestl&#233; Health Science S.A., to advance the program. CDX-7108 is being developed for the treatment of exocrine pancreatic insufficiency (EPI).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:13.8pt">The Company is actively exploring options to drive value by potentially monetizing other assets within its Biotherapeutics portfolio. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Organizational Updates </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:13.8pt">To align with the Company&#8217;s portfolio updates, Codexis is reducing its headcount by approximately 25%. The Company expects the majority of these changes will be complete by September 30, 2023, and estimates it will begin to realize associated savings in the fourth quarter of this year. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:13.8pt">Codexis will consolidate operations from its San Carlos, CA facility to its headquarters in Redwood City, CA. The move is expected to occur during the second half of 2023.</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">   </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:13.8pt">As a result of these changes, the Company expects to reduce annual expenses by approximately $15 million in R&#38;D and $5 million in Selling, General and Administrative, as well as avoid a significant ramp-up in expenses related to Biotherapeutics.</font></div><div><font><br></font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:107%">Select, Preliminary Unaudited Financial Results for the Second Quarter of 2023 and Updated Financial Guidance</font></div><div><font><br></font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Based on preliminary unaudited financial information, Codexis expects to report the following financial results for the second quarter of 2023. The Company has not yet completed the preparation of its financial statements for the three and six months ended June 30, 2023, and as a result, final reported results may differ materially from the preliminary results presented herein. Additionally, the Company&#8217;s independent registered public accountants may identify items that could cause the final reported results to be materially different from the preliminary financial estimates presented herein.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:13.8pt">Total revenues are expected to be in the range of $21 million to $22 million, which includes product revenues in the range of $11 million to $12 million and R&#38;D revenues of approximately $10 million.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:13.8pt">As of June 30, 2023, the Company had cash and cash equivalents of $92.1 million.</font></div><div><font><br></font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Codexis is updating its 2023 financial guidance, as follows&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:13.8pt">Codexis is reiterating its 2023 product revenue and gross margin guidance as outlined in the Company&#8217;s first quarter earnings release issued on May 4, 2023. Specifically, product revenues are expected to be in the range of $30 million to $35 million and gross margin on product revenue is expected to be in the range of 55% to 65%&#59; both metrics exclude enzyme sales related to PAXLOVID&#174;.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:13.8pt">R&#38;D revenues are now expected to be in the range of $21 million to $24 million, compared to previous guidance of $28 million to $33 million. The change is the result of the workforce reduction and reduced R&#38;D expenses subject to reimbursement related to the discontinuation of the Company&#8217;s Biotherapeutics programs.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8226;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;padding-left:13.8pt">As of June 30, 2023, the Company had an estimated $92.1 million in cash and cash equivalents. Codexis expects the portfolio prioritization, operational streamlining and reduction in workforce to significantly reduce the Company&#8217;s annual cash burn rate for its planned operations, extending cash runway into mid-2026 and funding critical upcoming milestones for its priority programs. </font></div><div><font><br></font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">The Company intends to report its full financial results for the second quarter of 2023 on Thursday, August 3, 2023, following the close of market. The Company will not be conducting a conference call in conjunction with this financial results release.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">For an updated corporate presentation as of July 20, 2023, visit the Codexis Investor Relations website, </font><font style="color:#0070c0;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">www.codexis.com&#47;investors</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Conference Call and Webcast</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Codexis will hold a conference call and webcast today beginning at 4&#58;30 p.m. ET. A live webcast and slide presentation to accompany the conference call will be available on the Investors section of the Company website at </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">www.codexis.com&#47;investors</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">. The conference call dial-in numbers are 877-705-2976 for domestic callers and 201-689-8798 for international callers.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">A recording of the call will be available for 48 hours beginning approximately two hours after the completion of the call by dialing 877-660-6853 for domestic callers or 201-612-7415 for international callers. Please use the passcode 13726635 to access the recording. A webcast replay will be available on the Investors section of the Company website</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">for 30 days, beginning approximately two hours after the completion of the call.</font></div><div><font><br></font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">About Codexis</font></div><div><font><br></font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis, and the Company is currently developing its proprietary ECO Synthesis&#8482; platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis&#8217; unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit </font><font style="color:#388700;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">www.codexis.com</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Forward-Looking Statements</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by terminology such as &#8220;aim,&#8221; &#8220;anticipate,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;design,&#8221; &#8220;due,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;objective,&#8221; &#8220;plan,&#8221; &#8220;positioned,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;suggest,&#8221; &#8220;target,&#8221; &#8220;on track,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. </font><font style="background-color:#ffffff;color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">To the extent that statements contained in this press release are not descriptions of historical facts, they are forward-looking statements reflecting the current beliefs and expectations of management, including,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> but not limited to, statements regarding Codexis&#8217; having sufficient cash for its planned operations through mid-2026 and whether that will be sufficient for it to delivery on critical milestones&#59; Codexis expectations that its Pharmaceutical Manufacturing business will return to growth in 2024&#59; the potential of Codexis&#8217; ECO Synthesis&#8482; platform to create tremendous value for Codexis and our customers by enabling commercial-scale manufacture of RNAi therapeutics&#59; whether Codexis is able to demonstrate gram-scale synthesis of its ECO Synthesis&#8482; technology by the end of 2023, with a path toward commercialization in 2025&#59; the timing of when dsRNA ligase will be available to customers and its commercial launch&#59; whether any new product opportunities will be able to generate revenue in the next two to five years&#59; the savings Codexis may realize as a result of its organizational updates&#59; and </font><font style="background-color:#ffffff;color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Codexis&#8217; expectations regarding </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">2023 </font><font style="background-color:#ffffff;color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">total revenues, product revenues, R&#38;D revenue and gross margin on product revenue. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Codexis&#8217; control and that could materially affect actual results. Factors that could materially affect actual results include, among others&#58; Codexis&#8217; dependence on its </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="background-color:#ffffff;color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">licensees and collaborators&#59; </font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="background-color:#ffffff;color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">if any of its collaborators terminate their development programs under their respective license agreements with Codexis&#59; Codexis may need additional capital in the future in order to expand its business&#59; Codexis&#8217; dependence on a limited number of products and customers, and potential adverse effects to Codexis&#8217; business if its customers&#8217; products are not received well in the markets&#59; if Codexis is unable to develop and commercialize new products for its target markets&#59; if competitors and potential competitors who have greater resources and experience than Codexis develop products and technologies that make Codexis&#8217; products and technologies obsolete&#59; and market and economic conditions may negatively impact Codexis business, financial condition and share price. Additional information about factors that could materially affect actual results can be found in Codexis&#8217; Annual Report on Form 10-K for the year ended December 31, 2022 filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on February 27, 2023 and in Codexis&#8217; Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 filed with the SEC on </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">May 4, 2023</font><font style="background-color:#ffffff;color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">, including under the caption &#8220;Risk Factors,&#8221; and in Codexis&#8217; other periodic reports filed with the SEC. Codexis expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> Codexis&#8217; estimated results for the quarter ended June 30, 2023 are not necessarily indicative of its operating results for any future periods.</font></div><div><font><br></font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">For More Information</font></div><div><font><br></font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Investor Contact</font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Carrie McKim</font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(336) 608-9706</font></div><div><font style="color:#388700;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">ir&#64;codexis.com</font></div><div><font><br></font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Media Contact</font><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Lauren Musto </font></div><div><font style="color:#1e1d1d;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(781) 572-1147</font></div><div><font style="color:#388700;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">media&#64;codexis.com</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cdxs-20230720.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:1cb7a91c-b7e6-41d3-8461-a3f2fab9c937,g:0f1071e6-ba57-401c-a5f3-a8991f751076-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cdxs="http://www.codexis.com/20230720" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.codexis.com/20230720">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cdxs-20230720_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cdxs-20230720_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.codexis.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cdxs-20230720_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:1cb7a91c-b7e6-41d3-8461-a3f2fab9c937,g:0f1071e6-ba57-401c-a5f3-a8991f751076-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_b7b64853-511d-4a33-81d8-e0a6efb16133_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b5415187-5493-4550-9787-e93dc70f6428_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_58a8b9b2-f1f7-41ca-855c-1524cda2a1a9_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_5310fc35-de20-4a7b-b5ff-f50ec9d4b71f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_09584f12-d72d-4477-9f9f-0e500573e330_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_f1684a17-bd7e-4fb4-999c-ab702ef425cd_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7d8ba0af-eef0-40ff-aab5-48957800c761_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_29b24172-c3a8-48f7-9d20-c4f999f8e5ed_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_08add1de-d02f-4c0a-b6ba-cc4084ed5ff6_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_63d7ab72-e8ae-47ac-8c1d-d530110b6e7d_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_6d9dddc6-3ca9-48dc-a1a4-df39b0fd3b2e_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_137622d3-cd28-49a1-9871-96713ce31fb8_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_0a32cbb9-7c66-4fda-aa10-f556f5146b8b_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_8bbd5b97-f4d6-466d-94d6-c76cc7b1c99f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_319f3c25-ec71-429c-a708-35554dda64c9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_e655f33b-14a8-41d3-9640-4524462034cf_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_ef735d36-3433-4730-a106-d34e938cee2c_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_b6b3fb07-a978-435b-933b-c3d6001c8580_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_13de3da5-14e1-43cb-a382-e10431f7c63c_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_eb003a88-7cc3-4b82-9f1a-31a988704771_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_f565b4b8-3bad-4e7f-8f42-bc458dd8ca74_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_32c72c15-b049-433e-803c-c074626999ac_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_6c51da43-bc78-4751-860a-43fdd102588f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cdxs-20230720_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:1cb7a91c-b7e6-41d3-8461-a3f2fab9c937,g:0f1071e6-ba57-401c-a5f3-a8991f751076-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.codexis.com/role/Cover" xlink:type="simple" xlink:href="cdxs-20230720.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.codexis.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_d95b372f-d354-48ad-baa0-f2c9a61b776e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_EntityCentralIndexKey_d95b372f-d354-48ad-baa0-f2c9a61b776e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_7764bb1d-5f0e-4b4d-a0a2-3100bded30fc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_DocumentType_7764bb1d-5f0e-4b4d-a0a2-3100bded30fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_1a53f2d7-d5bb-42a6-9210-7edc6dd5af42" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_DocumentPeriodEndDate_1a53f2d7-d5bb-42a6-9210-7edc6dd5af42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d4364015-34a1-4f86-bd6a-72432a205af9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_EntityRegistrantName_d4364015-34a1-4f86-bd6a-72432a205af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_6c8f144d-b08f-4309-8dca-f43223989c52" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_EntityIncorporationStateCountryCode_6c8f144d-b08f-4309-8dca-f43223989c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0c45c2c7-f13b-4e9b-8019-db71b5e59cc2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_EntityFileNumber_0c45c2c7-f13b-4e9b-8019-db71b5e59cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4237c736-b6a1-478b-839e-900859b278e0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_EntityTaxIdentificationNumber_4237c736-b6a1-478b-839e-900859b278e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_03301ada-9b6a-476c-bec1-5a866f709b14" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_EntityAddressCityOrTown_03301ada-9b6a-476c-bec1-5a866f709b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c218be90-1a7b-40c6-94ee-9b2502e237d8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_EntityAddressPostalZipCode_c218be90-1a7b-40c6-94ee-9b2502e237d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f60aebc8-757b-4a65-92b0-8e5caba3c6d3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_CityAreaCode_f60aebc8-757b-4a65-92b0-8e5caba3c6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_201fedbc-5484-4cba-8230-60d6debad7c8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_LocalPhoneNumber_201fedbc-5484-4cba-8230-60d6debad7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_9e3cca4e-d862-45de-a56b-c586e51a382c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_WrittenCommunications_9e3cca4e-d862-45de-a56b-c586e51a382c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_ba7e7f48-1a8a-4667-9d5a-2ca39dfd716d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_SolicitingMaterial_ba7e7f48-1a8a-4667-9d5a-2ca39dfd716d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_d76f1482-3946-4dde-917d-b407deddba74" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_PreCommencementTenderOffer_d76f1482-3946-4dde-917d-b407deddba74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_60ed5264-edc9-4c94-8157-67327c5dc725" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_60ed5264-edc9-4c94-8157-67327c5dc725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8eb3831d-974e-4374-9834-f62717208afc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_Security12bTitle_8eb3831d-974e-4374-9834-f62717208afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_7115d649-482c-4d63-8030-03ba32b0c8fd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_TradingSymbol_7115d649-482c-4d63-8030-03ba32b0c8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f4838dc2-5bf4-4acb-8ce6-1cc9dce4d24d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_SecurityExchangeName_f4838dc2-5bf4-4acb-8ce6-1cc9dce4d24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3818a40c-4ec3-459e-a6d6-888addd521b6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_EntityEmergingGrowthCompany_3818a40c-4ec3-459e-a6d6-888addd521b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_1cfe3630-c6c8-46f5-ae23-f39ac59db244" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_AmendmentFlag_1cfe3630-c6c8-46f5-ae23-f39ac59db244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e00114a1-cf50-4682-b2b9-5662eb5118bd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_EntityAddressAddressLine1_e00114a1-cf50-4682-b2b9-5662eb5118bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_03875462-ef29-4ca6-b098-973d1e0f5cc8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b2b7a906-a696-4490-bee4-8bba87db5d66" xlink:to="loc_dei_EntityAddressStateOrProvince_03875462-ef29-4ca6-b098-973d1e0f5cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image.jpg
<TEXT>
begin 644 image.jpg
MB5!.1PT*&@H    -24A$4@   /D    F" 8    &)SUJ   >#4E$051X >V=
MAU>5N=/'^>=6=-]5='=M"&+O#0OVWK"N703I8&^ 8A=$BJ"B8@&DB(@(B(H"
M"K9YSR</N??A\MP*W%W/SYSSG*<GD\E\D\DDF03(K_"+ [\X\%-SH**B0@Y%
MQ4A$Q!*9.V>^K%Z]3G)R;LGGSY]5O@)^ZMS](OX7!_['.0"8UZ_;)'>*[LK[
MEA9Y__Z]O'CQ0J(.'I*#!Z*DO;U=?H'\?UQ(?F7_Y^5 0T.#;%B_24H>/9+J
MY\\E/>V\Y.7F*< WOWDC\?&)DIZ6\0OD/V\1_Z+\?YD#/W[\D*P;V7+IXF7%
MAKR\?#ES^JQ\:&F1Z*AH>?SXB;2UMLGJE6M\ WEK:ZN4E95+7FZ^7+UZ3=+.
MI<O9LVGJ.'<N7:Y=NR&%MPOE^?,:Z>CLZ)>R:&QL5!DA<QGI%^1<5_K0D9EY
M27)R<N7!@X?RZM6K/DT?YN;FYDE:6H8MSSKO[L[PZ?+EJY*?5R"EI65*M>I3
MXIQ$]N'#1WGXL$25"^7CCDYW[\^=2Y/,"Q?EW;MWEBG6?W@EF:49<OYINN0]
MOR7/WI3+^W;K;RTCZ,5#TB&]O.H<N526*:=+3LK)DF-RMN24-+4V6L;<U-@D
M%R]>MLDQ+>*=.W<MO_7T84M+BSQ]\E0*\@OD_/E,.7WJC*2F')'DI!1UI*8>
M5>6 /!05W9&JJFII:VOS-'KY]NV;'#UZ7.[??Z#^N74K5_[9N4NN7KLNITZ=
MD?KZU^KYLJ7+/0?YUZ]?I;"P2%)3CLKFS5MESNQP"1TS3D:/"I&QH>.[':-&
MCI%Q81-DT<(ELGW[3D4,-8O\^.%Q)JP^_/CQHZI4#AX\)*M6K9&9,V9+R)@P
M"1DS3L+&3K#1P+/@T:$R9<IT6;9LA1S8'R47,R])75V=5;1>/8.Y2Q8ODTD3
MI]K2<\R_JWOHXOVL67-E_?I-0F'?+BBT&4F\(L;-QS7/:R0EY8ALVKA%IDZ=
M(92+*]H\?3<N;)**J[2TU)*"_)H\"8H=*$') V5$8I!,.SE15EY:(OMS=\N%
MI^G2\-$00,N??7C8\KE%52:'"O;+RHM+9/JIB3(\<8@,CAL@PX[\+G^?'BQ#
MX@?(_3IKX-XO?B!C1H^5\>,F*_Y,GC1=(B.W>DW)YX[/DI^7K]3D31LC9=;,
M.1(6.E[):%CH! D-&=_M@-_(P_AQDV3^_$6R)7*;)"8F2\Y-N]',&1'?OW^7
M$R=."8T<(?=6GI+S7;OVR.5+5VR_+5WB <AIN0H*;LNVK3MDRN3IBAF "N(
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M?U-@ W"#XP?(T)1!ZCSI9*@<R-TM'SL^6L;CZN&+=\]E>U:D#$\>HBJ/H,1
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M+2T?A'D9:&'W[A7+S:P<50F<.'%28@_'R:Y_]BB#'%YW*&=PH'&IY9** !L
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M/CY)R;^YPL<5FS,ON>;_S=>VEIR'C4U-LGW;SAY UX*'M1>U6F_!8H[(ZAI
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M.-0\<N2XVG\<^=RS>Z\D)"2I9Y<N7E;["-((LF:"?_LR_#_E])+:2&% C@
*  !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140105487231840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 20, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001200375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 20,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Codexis, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">71-0872999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Redwood City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">421-8100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CDXS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">200 Penobscot Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>cdxs-20230720_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cdxs-20230720.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001200375</identifier>
        </entity>
        <period>
            <startDate>2023-07-20</startDate>
            <endDate>2023-07-20</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0001200375</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-23">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2023-07-20</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Codexis, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-34705</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">71-0872999</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">200 Penobscot Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Redwood City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">94063</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">421-8100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">CDXS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .J ]%90_K<][@   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( .J
M]%:97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ ZH#T5CY0 "A"!   >A   !@
M ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( .J
M]%:?H!OPL0(  .(,   -              "  84,  !X;"]S='EL97,N>&UL
M4$L! A0#%     @ ZH#T5I>*NQS     $P(   L              ( !80\
M %]R96QS+RYR96QS4$L! A0#%     @ ZH#T5JK$(A8S 0  (@(   \
M         ( !2A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( .J ]%8D
M'INBK0   /@!   :              "  :H1  !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( .J ]%9ED'F2&0$  ,\#   3
M      "  8\2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(
' -D3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cdxs-20230720.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.codexis.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="cdxs-20230720.htm">cdxs-20230720.htm</File>
    <File>a991pressreleasejuly202023.htm</File>
    <File>cdxs-20230720.xsd</File>
    <File>cdxs-20230720_lab.xml</File>
    <File>cdxs-20230720_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cdxs-20230720.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "cdxs-20230720.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cdxs-20230720_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cdxs-20230720_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cdxs-20230720.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cdxs",
   "nsuri": "http://www.codexis.com/20230720",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cdxs-20230720.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.codexis.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cdxs-20230720.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.codexis.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001200375-23-000022-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001200375-23-000022-xbrl.zip
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M-#$Y7?9'V$.2 L8&%L:OOM"F#(Q^#S::69. PB[;[\;#('H ._[!RIB!::%
MV>-W\9,(^*D44V"M'%YX!2\J%<KVWK<#X8WL0L;BFZ>CP5" '"5X9KAD!+-T
MHOB#^J,")RZ!=<,[+-+O'U6FQ-BIB!Y]T_.B52("N@(S"N7L-_(_DWPJ$S(]
M2W@5\)JPU0QX4CN].JO<*<.Q9P@NV_M-':1&FIE+370/3PI_-GENBK+*D/WA
MEAALVB7:*=@2\BVR!VP3#L< 3P"Q$G)E'3%;@+3+@H-/U^,W"61'HYTC8'")
MFJ)*B,E!81!?ZIRA.E)F!LQD6@S=JSDA,TNX>Y;0F4D0')V4_=+TESKKL63@
MD82. )TYL4A1.SZS2B7TZD:JO-90R J%J>:+X"P;&<+SVZA!\&E;SZ9'!!@>
M"2LU^FLJ7ZA,G *3@39^]>+%>0]TQ&D/,8X%;>.=DH56X(5<J0B$[5*)U\B+
M#&H<20;"4?;%BLA!RZQR7!4L";_!NA7(F<T9:J[;A9Y8*N#U1(/XXX\+"7_2
M*D ? T4E"CGBG()X<0X$RG$-N2GQ.\"QJ/3Z&I@\*@/=#WI"\3KHE2S^*'+@
MGJ,02M X!>XK51(/>E8EP XS!UHL03HP^""$*( .#^9M50IG#GX]Z):!>'W=
M(90J6F3 X&"N+$H1R3K8!Y/7FC8!0O7$'!:3L7S76P.&X7B2 !J"9HS!%#K[
MA.OSK(E+PZW6ZT&EIC(Y39SA=4S3M[!JV'%M 12N@9RIMEZ5L(:E*H F/:3X
MDAZ32$O:+54Q*"54$%-%RIT5-RL*&<<%NAI(2AVAJ,%%E*<2A4U)"[?Q6>&M
M3J?28W-@:-2A \^M=UBC_ 2H)!._F*)0)1P=B\IK5L>PK751Z2%A%""'1A>A
M;@6B@I9!5K(E(.BUHT VC=&\(?\RF@!Z+F41L\T"5FC)#YF2J()EH1%=& O_
M@3AH]%; [J@4. T00:K*A0'((A/0\[6UJ9!A\/F!W0%SR#R3U_XUV1JE2J^0
M<,-+%%K8+< GN"\G28T5\%D\$+\UR_/\"O^"#?JC0FN;&Q +>"RS3ZP0B3'6
M(GR"+Y/%A4*=Q*(LD2Y@]2M>#.[8,1TI4'@V&-@$S/%<T<O9S/+#4^ U4B0"
MM803!^M%=JLR#>1XRL94H=0Y$5X!3.RQPI?(R0M_3"26:UI[;N#(V?/>0ZQ1
M 5QS&$%F+2H6M;\^9W\=)<6YK 5[GQ:?A._Y(* 'B/:J].M5\(P4P1?HV!FK
M?B(H?"!1.<"+"QE=,()12=)OGQ:(=8)@=RMZ%HB>O5#_I7A?&+'V"S@D< (J
M<RV&[>]R,=F=YA8Y);99O^4]86_^_Z+P3\Y!5/M3V/Q%7\Y@=X<R >MN'WSF
M4/M-J;3-SNZ;&O[\,R>%<QL.YBWK_(\,>_R,\."<X8']N*4WK!0C:NHG:E8>
MCO=A(13=T1G*XF%_>)!_ILQ*$]NY;DL[$P^5][?%?&_B[.'51RU*#,<#VKDW
M&&2B N\:45+C\R-*(H\7]'KH16[UN4&)P@,5><C;T3/<,>,0A@3+B)84'A&B
M2HD/BPCUD/EBY:C8G**-H1\""\J@BR('A8^2/4;;_Z2#PQKT;U.,HOD[\ H^
MX;'5\,<3L'-H.@SZ<KM[.R&,0*_" 0+VH6O$$5 J?%%J"L(1F=C= 7?6JI+L
M"]@60,TCVB__/&X>52+CP3G(8JY*Y^\CU(,; 2HZ%W4[ZNLYO$"XEG:%*"&O
M\T= 4%.5\ 35X)N&H)',.:JCV1H&T 0M'>#S%P$@QD\[&)@]\Y#XM2_6PAUP
MJ52U3XC2,IP<O1<P8) $0 B92'"Z:O>G#9EIT1ZZN.@5<P_'JY Z%A ^V.OZ
MDK4&>+OTX &L=4RV#@[EO?!O$/@/'G#8 "0AJ:Z#2;C6.OK4QD,<\VAB$%)<
M*(1YP+MT)Y*%N :0 D5N&%)Z<5'H8&/<K]^(;NW8P-WL4W:7  ^8@C.=^73&
M8%T=WZO<#U*Y[X*041VA0A!^P6H77% XISYR"% L9C446U1#X,C.4>KEI=2)
M]R4:G[0^&G!^.@+D(#YZ^9Y5X-MKCFD@\AR%I/?ZUZ)RG'-FAX2A#D!<)PF:
M;0=\J8P0L(/R@I>QJNV%&H)CH!CD9<U]SUV?@[LPC&F;&#ZH >G%OX[RN("V
M#\R4K.N\\=VL1QD+7/7 QP1-!SZ(BC>$<X+8S3OTX-@"JC76S-2RK;%/:X[K
MM>P]V#?0>8H^(Z6FG!,=L>JNHSJ8RT@2LZ0UP6L+-)7 8BI#/^72JWHRQ#("
M:R<)UX#B+%W\V601&Q:9YXDWL!QGYH@O[.#SGGB7V=9\",=LP\GN+? :. X_
MZA.9DS+*30+,4=#Y+!<:))N"_@IC#DNP=!B:V*##,#\A,<%+1*:$BCL:*U+Z
M A";4EOUL=ZK@<^A!A!_1.C))V1P8#&<RZD3&QRFY;C"=-62(X J #C_I!M(
M=SO BOI?<S"U[:350?X-9W='74TZOVVAG7O'\^8<3_!T,*MM,&,(D,$4*W;^
MFK2VTQ+P8YUXO1)3;2)*YMK2F1YTC:Y-'Q#8H">SPL+8&Z:;..1+$$;G*J&8
M^X: ?1 E)G#ELUR,D1H_!-V\&2C&LJC8\6D[R!C.BQ8>6COQ=&;P/15&=7!1
M7Y.#QB0 /'1["O%>G7Z.,(E+M#/X-@D <4,(@K.1-1HWV?8C=:YWDS?CM.>F
M>#3GKFL6N-8#N\L*ME-:<!_-NV&K3ZS:E(4HA,3L]=?Q*?SP4H'R6)KB8F/Y
M1Q.UTAEP.4#NHC"%2U*6P/B)MEP<,U>9#^^L'."/5:0M8KTZJ=]!_IVZ%\J&
M8.0(R]L0C9"'&R)P'UK$YYQ=F@06SX@8]E)P&$M=^L15JW:'8AD^O-DD]NMJ
M#:X-D"5GQ^G;88X8=T<R[C)"3?KEJA3ETI"3A2"*@V'W_/MI:E:[$AR7GPRY
M&(]_;^?1P]W)T=Y.*QAM*SI-R@F?_JL_&>X<L)=!&I,1,!S8W*"/2]S4%,')
MHH0#[HE?E"V31P]'X_&1^%')!#YWR%:<#XX'/?:"79J86(JJ(0;-&_5ZTM[7
MKE*2GI:*".?*1& &X!$RXR*Y")99YX7!I7U\]N;EDWM6NOL.4->R;7.![C.N
M'P=0;JS?)FPH 1WO4K+WJ.0F1-%PX7%3+MQU?9K*P(K/H1=6LM0EI;[@=%M9
MZ<;H.J6C?D?COVIR4;Y*U%?GU!E.>/"YRDN53D'<VT6FF!Q)B5%TZ6_$I$A0
MJA%DC*R\A&77^;*9J0H@P!]-[T)=V7+OF7TNS\Q5*ZNP=G=6F)28YUQFXD06
MB4$&.Q;@BW&6;U,Q,Z9'5+PT)A8G\!V\@;DKQ1BT]M7%+G.*4601LV-'!?'<
MI[*0R<RG[ 8W&S"^)FPK[CGK+W)6IYJYI33:)?I!%H\CX=A*48%5P0\RC&^O
MZ:IOAGMAO?O;1P_'!T>GI&.^:7URKI*$BGA_(!<DX:ZI&$RQYASRI>IA43P6
MC^&?\M)H+)@(*\8 H>;]*J?R8+^BH/2\@U_N1J'YYOS'.66O>M<TBWT/%S(*
MM+VE8[/O:1LC6K+E#V_V#6IW@@[KA5&(7EY00HM:<1I"5#4A9O5>=(8NL.2$
MKM>5+7XEGXG-$^;,4($UMQ<=.CJU]D>;CFVKBQ'=S& %9%G;5.^ *_"T6D5"
MS:ML"<>04H]'[3 M"L4Q5*NO$(F7"TQ)8D)I0P.(#..R^-S$[8Z*/'D?J?2I
M3H&"6##&)_O@%EA3T]\"UZRBI!86O.ML -+G2T"PO'\3GD$5FBO2H_"<.4@J
M)3;S:IJ FR<C C R<PMRM?CP Q# A2'@&PEVOU1<-'/=?J@J(]Q*G<?=O*F&
MW V26=O@UXZ!24)NQYC JZ_#P"6=GZLGQOQ#B!^F=42I0/N"TO'-J.F(@F]\
M,QKYO_JL:YU0WU2NW'[6L/VL8?TLDAQO?>K[L="\8ZYV_!U?143B+K+ \:;.
MM;*E..,MC6]XC&&;W-TPTYLI'[8AY*YW$+4]&=U&!\V=H24 P^;'4KOKO0;Z
M_.S7<JBY0[]U+!TEPD']PEBT43B"I3XM:L&L2N[I<YJF:P!GNK!E#1/ P<W(
M$09+Q%6KUE:,7UZ!_=OM.11Q'I1P]M:UVH<HS?%.2]&-]UJ*KK4?;F1N[;GC
MU6UXP=[>M_C)_MZWP*A/C\04H#.F0@H,_*DK4LB^!\^"Y+: ]IOC?_W\^G]>
MGG+.XEZ1_D5.7C-7/IO_L19UM[&HU#OORMQ\2WS#\73S09NSQK4B)O3+CB%R
M$+TS=!LIO0:8-E+L'M;U3^PL-O:W=LYL-?W=M52!K*;3JK#<Y!XP$U5GUHF1
M&E1ODL:U +7KX?PJ./".A@;>;\JQK-V![(_I<!^LNVF4C?01TG86L]?$N<B'
M"@8%U!SFBQH;-L2:W"8^D*Q\V&(3\[A0!BUSBI4)E >ERLJ-G?(]6#?.:Z".
MUJ U6V=!"STM#MOMZ5N^,[[*74M!T")?OXBWO6J8]XZVKQ*_MK)/S?@*YVV3
MXULER4<[VFBSWBU &\02#.1Q-:_ RHX] S8./#4Z),:2YN+2[[:/3M%2=-(I
M[IT1DU G0=1,E8FX'P8O_5YE4=-P3U'K]:4[XWZ]4OF/SGE]J0:_[X&!0/-4
M+JH5F2+GZB3GYKOJ6Z? @D$[/7&I@<!-?3,<\DN:(X+CP.B4*&>NIO M@.Q;
M!_-,=J*;&,RS7"X'D1N- *J"J@"T6^.MM%/>#2=L<[]I=T 4JMS?U!1T<GDG
M1D)MG[U&&FIADGB#4N)F:=J)FW5$63BV>NL#L 8"^PEH^ 7?0Q'%!,?^M(0"
M:SNB*!CFTGVOSQ0V[3>N8LG+B46]O0&)>:G!U6V3F[W]<32\0W)S8Z?L,'.'
MOC%.T "+DU68>F5<?S"9]"<[>_W1T\D^6<?8I BK(KK%3QT:[0S[^P=/^P>3
MIP>NZP,4>N9QD?OJ9Y#6&Z/(,=A/4-9QT'MW#<_A]G8/0#8J'$/2,'XK8(<U
M:?P-,FV^7Q.#\0%[TANF*R(\/@.)O;^_ Z3<&V\F-EPC6@]'_<GN<&\+K<4;
M]O5]!#N7UB(/BN%X,MK?!\^<Y<TW9M;;1W'UD@J *9&K3Q>\6VVU_Y)LA.<!
MF@]T(@#Q3V>.NVS?CJ>F*CU4N1/KW&[1M/V@\7WPE4OPI>8^.!>VT0=UKY^5
MH_<'NY,/V,L&U%Z:_+ _'NP>K ]FGH+TXQ-NJ6N-93#H$0];F7WI<\^7:7)U
M#P_D \<(KO5X[!7XM91!Q>OA2 (N!J2139PP@7,JE<Y"_]U]W>*!D:;$&J$^
MN.&8VFOZT+L]YCR)(#6)BJJDV]-B@[99[^73'$-*+.JXZ2(/VQ7K.LAF4H';
M^"8VV]I$$K22DZ.*K>OQ>R=>;6GV'W3+PGER44V^9I"8:P#E)+&ML(^'NV'@
M)%9:)3'LV<?4L%H"#KVR./6) "/8$^4+N2ERXAX7AWVD@#[6Z3NG"6%%JX$4
M ^(J,RF2';X"%G2>&3*58<'Z0* _1HVFK4P\NUI;)&)\<#"Y$0/1@8)?J=-T
M8Q-IX;APJE3_9V,N\/C/ZZJ$.['HS02E;HN<6K-]AH6:;75& 27:4.(V%)19
MN!)FJH[D$7THNN<.2(TFQQX)P*7*S4\\CBBJ/7PZ'E/63J94C\&ZIKYU>+;A
MUK,K%R-OGK$;/F, : YT98K(PV*)U<I4)/QU?<26O>"$#%6DV@\"=,K!#8.3
MNAG1Z"_5$SG6/K&V2M>NN@EKW<M(9Y6B;MSX$;8LK%^ODKA[D?O<UZZNW^U#
MRFO7*5C<O8ICT+K7.![9O9K*5?>2H22$7M\T!GW7KM5SR]8_<=7T:Q\4..=P
M;<U6J8NU:XM-1+/5'&<.=R_SE)RUW;A1:]WKZ%NL7<.W^6N-M;<:A%;BX$T2
M-NX>H/%X!842<#>^38G\(IK- Z:_(KN(Z2K7[N>NX-Q.-%HNZ)NI.:&J8%X.
M\#0Y70YN4):*;6_#[8.-AF0*>\4I#UG<=_IG1O\<W;1Z?\>Y*<H"N&EW@: Z
MQ>13QVN*BW-Y)0Y^B J=U_3DYF!*$Z!QY@K,%7U]BUIPG6=U3-P--B)AGH6=
METU_65J/6@_:WWJW,H9\"OX-T@++MSCKUVMO;BXY8- !4 NJ.P^'&U,BYOJ<
MS=I87$9,"Q[7P@,+UR<F\_.",<>K:^8<<ZJ\G=:J7RS+]_]^A;KUE5:QUB'K
M&F+Y->W>O69 Z-914B&XO85YL+QR3^_0870S?CYDL.:U$Z2O':S)8?\-,S77
M9[JY49H-B4N=.L"PQ%G'K3E!Z^&:UI@B/TL]:(Q/9)5%BS89T&/)U+(NTF@W
M:];O<(__N [-9A^^1\,3'0LRFU:.5@4XKMFTVX9<NPH_#O=UIS1QA_-;@M<H
MC]M0;93,O%.T*EL%FNO51[UNE>2'%!0-Q+\!PS)X(4T.>B;".<  [-#B::XN
MR9RUWX9O55T+C+XGQ8#$16:67$E29?QSH>V%Q;E,;N8_B4H#8% '8;#4@Q;Z
MI1 AY.9?O]!5F6BS"Y.X>$)=G1R4'<O9#.M54,4U&6%P?L/W?=A-OJH5/(/4
M^*9+ZWX)1GM9OL::28C2>9]ZWI9ZOC792G2$=4V.%9N1&<8KXB_<&75]>/[6
M2*1GP@VH8<L8D,A!?<(D<$^Q\?=XH$[A2+[&,",.PR1/PI%>R'FA K>_$:40
MF:'MPV%N..A-U^F<'$=\U#V,[+B@MBOHA0;-BK?H'J>U'KM97&6-:CG;%XS=
M=FS2S.YI#7?#_GNXJC!JY[M8.F]J)J4X<OI'^2\T+W+>1J$BI3$42&U4/BA"
MA3-N,WH6XK)FDGL8/PYADPJQ2U/&Q+[IVJ/1L5.EIN-N[S;\9+DP/)_"!R2;
M";WU[U[@804T7M:OUR^Q1=X:%-:3+V@ 98>2U]]B4!.J4C70IYXB#RL!BT&A
M4:PMT@PXF+G8P<5!N?SK)/P:_9'U@L*B^F9.V"_8RP:&#EMPPK@J@$%,"<W^
M@M7!.-.46G1I+EV7#L=<!/>6Z[?@3=^CLS#<Z?]45VPAKG3-2:? 3=P\/*3:
MFA%LJAX_WXF*\2]S=)$Q_#6%F@(+XK$+19R?G;A Q!-ZKYH6%<;H1Y->T\.V
MOF#7Z9:L-JSYUWK-=8$V+?N5+**%7_-X;<UG)_B0VT"+09'XG5+:X7R<6O^B
MQB1F= ?X%B"9!T*],*:T?F@,TE"(38S9$3HYN^$@6C6B&#ZASB\;)5*G5M1%
MAR5%CJ;UO,S2]]>_%V]B$6>D\A)=H *+4[$T&IS'1"ZWM3'?7"BDZ\K4A;7=
MPLDV2[=*=&MMGRFL.O"_](H':'/4C5R\^K>,A,]&HCKCQP=T1_IDKZ\"?(59
MIY>-=KRSR^7:\ACK/VBAAR1+G#JN*Q#Q=[N"$-UV+E\68&'%J^@GG=[R4AZ/
MQ_M/Q/[.0?_I9.>Z7_/[I;**NGCT<'_W:$-B\:OBME<JUK++:E^T7N&6F>IG
M"0HN$Z\0,-_V6AY/#H9/Q-YDU!\.=R>WS.#X*[GD)_'XW0I%?,>_[OZ[19DF
MS_\/4$L#!!0    ( .J ]%8L;<B 8Q8   F/   1    8V1X<RTR,#(S,#<R
M,"YH=&WM76MWVSC._CZ_@NO9W4G.B6Q)MN-+VNS)N.F\V6F3;)*>F;-?]M 2
M;7,B2QY22N+Y]2\ 2K)\2Q0W][9?&EL4"0(@@ <$Z7?_NAD'[$HH+:/P?<6I
MVA7VK_UW?[.LWW\^^\0^1%XR%F',>DKP6/CL6L8C%H\$^RU2E_**L]. QX-(
MC2V+WNI%DZF2PU',7-NM9ZW2AZKK>/T6[SB>U6^)7:OA^'6KW=AU+%X?N />
M[WB=>FMGV+4'CMURH$6?-UM6PX87>'-0MWB[TW$&K28\W=WQNY[3<?Q=U_';
M Q?Z&O0]>]!N-=NN[?>]IG!QV%$,\X,YAKH;R/#R?644QY-NK79]?5V]Z:N@
M&JEAS;7M>@T?][D6%=-\KN5UG=HYG4ZG=H-=IHVZ\F9=CTZ])D/H4R CL^8W
M2S3,]8Q/LZ:^D'E#ZE8+KSJ,KFKPH(;,G9$06_!LKM>L[8R"6JQXJ%%2/ 91
M(X%-RVY;=2>G3<M5E %OG-KOGS^=>R,QYI8,=<Q#3Q1&7\V!VX9V;<MV+<?-
MAX:7Y"VBF1NT&_!P^+XB0NO+>04$++B__VXL8L[P?4O\F<BK]Y5>%,:@N-;%
M= *O>>;3^THL;N(:";"V_\,//[R+91R(?<^_T1;RU&ZY]KN:^?)=S73=C_SI
M_CM?7C$=3P/QON)+/0GXM!M&H0 "Y$T7&PIE_I2^+T+Z$YX?P^I1TC/CW\1G
M8O"^XEG \I"/L2<ANX<A##?M 76*!T>A+VY^%=,*D_[[RL!RW<J^#0) +K2:
M[VISO=YCD -8Q#XNY(\!'^:=URO[ QYHL=1O;7XB2@R$$L!_O8+_J+-=3<H!
M(S/2X6X,7']?T7(\"5!H]-U($6%%5E=OM ]=U.;[,.//!DUIT%&BZ!-I2S>=
M+<T%9YM]+XB?V2?IX^>!%(I1_V+E,ND=_3K/Y\67][.OYGN? +LB/_L$.JKB
M#V F]W%^EMVR4)D6G^5D^FN:9D^RS]D@M;EY9TS*N5(KZ&$-M-6H+')'WF4G
M_X?<F[V3JOE8AM9(H"WO-MQJJSF)]ZZE'X^ZCFW_HT)-]]_I"0<=Z:L:=&#^
M-OTL]\;5$#J,HTG7A9YP"A8/Y##L>L!3H2JFKZRY%P61ZOY8IW][ YBS->!C
M&4R[/UW(,2CBL;AF9]&8AS_M:+ N8 &5')B&6OXENDX;1J&/UV8.+=O>0XN4
MS<EI-6 67XZ/+@X_L/.+@XO#\_DI%(A_*=2>'_:^G!U='!V>LX/C#^SP]][_
M'1S_<LAZ)Y\_'YV?'YT<LV><@UMJ#K]Q/9+A,(["'?:AVJM"H-!L=)Z1[OH"
MV8U%LEU4]W_^Z.S:>QF5#\LXNQ0%_[OKWUH6%M9>_66L/9K0QY.SSZR\#\MB
M4>/1C0L#P]6V?EWT7\^Y"!Y+ED^M]+16YY7^^?5JD>K5%@9LY-GA\04[.SP]
M.;M8KPP%\G>?A/QR!O(T43KA@+GBB)T+#T-FYM39R1ESFEO^-HL&[ ( &#Q*
ME(PE#'QXXXT@)A/LP(OQL=.I-U[=M#'F0>+/Q"12,=O*/@L.48_0,1-7"$05
M/1;^=G<#TW%*H=2A"; JS$ 2")!NXJX/WUACZ&*$KUD^GUI3&-H281XN5_;_
MG013LR9<>X<0[G+H_.8LS[?CB-U&*;]U7VQW)H92(P:.C^%)IDX OGH1H#VI
M=]A1Z%5?LA-;O6*W#F\X&!R<+BY4E4^3<<WT1'@(G7PF0R9CS<!$P;I5VR]I
M7F_(.<>\'XB,@GZD  =:0$C )UITLS_VLM2%2<Y8]-)>ZA#Z41Q'XR[BO"NA
M8NGQ()4&"<8\3B%@IU-M-SJX%F* F[&?#9P"Q"HMDUKL+S^K.]7=MK/VL5W=
M]%G#WNS-9R&VW70?A]AFJ6YK)#4C.= -U*#WE7HE>V'"?1\@&@#U&^:L"A$6
M%<3HQM.;(7L3<PS&-E(01% R\CP&O]^+DC!64S3'<T$!IE4Q<Q.+B8JNL)]9
M--" B$4$_)JK%>FSU#RD8KB%PS;RMU*JZ=L4QD<9"&C<!V.?,K:)F3C'JC=:
M]G+"LSQG5[ K$(,ET_8XS&K=9<#MY4CFFU6!"WYSE"9:/5J3\_JP6]EO.9;=
M;KF=3N=6A;C#JJ5.$7$/,)'I*) ^^]&&.6RJ,T\9NRRJU)J0C.P9BQ2+XI%0
M[ ^ B-J7!"+O H2I_[>KS:= A>7F V&E+)KK[84L\X-8V&]",7K1>"RU?J5Z
M@&Z"&;MP?Q5X2Z[@F]#5H^I9];S*#L>3()H*]1H5=MZCL>.HNDIOR6/5"(7=
M P^OVF][O->>,'S8*+MRX/M*:)W^]PGZ<[+0H579=VV;G8HPZFLOBMD'):^6
MPO67E)!8K4P;LJ0'?YZHB^@Z!RWMROZ9\*^CR&?X<)$3._=(J<Z-1%''B3H%
ME"2I3,,,UZGL]PZ6V;W9&*<1(+'@OW)B8%JZ_V-7]CL->W<I#_N,0BUIY-)I
M8>;L5 '7Y(0'[/!&>$D,2LI.!F \A-YF6S!EAG.^)7-62.EW7H0-I)7,9HG/
MGS2+12 FHR@4+"0_OH.179"@SV( HCDH@B\8>YH=UM4$;Y5735P^!T#UG#(Z
ME?W=IKVHBMOWT/A/$7CH4^32/ ARW,I^PW6L-H0+Y57]R7=ZRIFS8[#$!Y-)
M ,X1<Y8O?J5^C!1P.LUS*TH0P4=NUB^H\8"9[3>?:;1^+. ZVZ?:(-N]QDV_
M@!3S@Q+0*45 ;R2\2ZHWY9.)BB9*(KSM1S>L+X+H&GF/#U%"K&W]R@8R0'LB
M-1B76(0^R"2.0"SC)(AY**)$!U.F(2;3@RF]F;X0]4$0)E2+3)>%W8P$^@%Y
MA]/LV2 *8'!\#_."$D&59EO/QB:SL'WAI2"Y2P1CJ\J^%N(9Q<=^$:%0X->.
M0N!E8O:R#ZINU8@/]W"?9_NB7MWMU#?9OG"KCETNQWZ?7CM-H.>Q4_</@7D/
M8 $&[$LHR5E_/M]4.^Z9*/Q-R1B6,^8PDC#%5'HY5=^/HJ#/86W&8"%RUUE'
M.]9I-1I[KS6=7(Z=*9-@%@4NL4FAFN0L@376<)NI18OGJTBP>&3+:;'>QS/F
MUNTJ--R^3W[U;:K>>01Q"C H''X&UX,TE-6[QC>B=S,.L7'*HF6M<QH<@MB"
MXLW5+.5JUP!31RV_:U[W5 DT>%@"3V6/&,XH@(6("LII8/,;T4#@E.456#5O
M O4J;?0M=ZN_74X?3=OO&KFHD4=:)T)MH)>[W_5RC5[6A=78\LKI9=IVA5ZN
MS2C/A\I4F%G($31HHVP%GVSZ]RA\HKQ+(0@QL$LH &Z3576PM&I3& 8<Z3X/
M?@#Q5FVS>.Y=_P0(HKW[X C"!0316/]XXYJB=K5M4M!?"TQ2F> 2Q0- Q9VK
MPIZ66WI/Z_Z%#X^HQ:0*%WAJ$'7SD'LCU@NXUN4W]-XR7Q1'8A^$%W2T^(WR
MZ3BMHR7UR<T^&+W?1A*^.<LMXP9%+ZM8>O\*B=MZ>14L/I^.^S"[+;W]>-JX
MDJWEI)2ZH-6#O6$+<0\T;B*%J>/VR=SF(64+J^G'8U@MYW'D7>ZP"5?LB@>)
M8'\G7^VP"9X!'FU6K_E=0"4%E!I[L]!RZ;1!.A]^/W]ZQK]E?W'_59,Y%7,,
M91&K"7@Z7^/L=,![0Z!]S+7/_V2_!!%@.8C% XC&V6>N+D5\=T'F$AAY8"BV
M>&:G3('5$Y\J(0J.0A^!GV#]*?-H6PN QR6['@FJU%S8<Y*: 8F &A&;#-E0
M1=?Q"/'C!/>AN&:^&, 0=+K&I'7M9H:+%G*ZYD!@G6TA#UI[E-K-&DLZES.A
M<SF12D&HV[?<%7VM/&68=8J =/9>H=MJF0U06J9/?]J'Y'*XAL>W52)LOK1+
M$G7?&IEL$K_0''IF"B73,:Y]9SKFU:#KSF[5;K0>_,".6]UMUI]S>VZ=V7QT
M13P:W&*'L(1GI5&32WOH(S!9Y#? 9(41Y702+:@5L"#=J<=K@J39M:*#NJB_
M-%8PQ<'I[BE<FB',#9XH<24UO >&D(<>9D2YY^%1'FR,%P;Y7/G:[-'[ZQ)*
M]2V>)Y1R"_<\6^;$<#"N"R9SLUPHF=2G"5=*JE+J@I_2LCGE$LVWQ2EW5,TN
M7) SB8P"=Y4(.-;Q+5V9,[.BIFAY]@KO0R2:Q.M?N4_%T.(M/.7N 6KE]P"-
MU$S'AL+J*\$O+3Z 0;L\N.937:D]XF5!*%(+9JNX%W=U,@:C,EWP).TU!6U/
M7DC2W&UMXJD<N]JI/_R)U?9NM;W;>065) ]ZY.PH%N/T7H:J[;Z63:22DSL3
M.@EB*A0^ ;^8[AV!=V,?<\?7B\ 1XX/J/7:#4B88_(QW]CQ]!.[@,>B3D.'%
M&BR[4X/-W8O MM U__/'MNO:>ZG]IT_.WC9P(02'[X%S]T!B7%+Y'MXV, $#
M+,$H@>%@2<@3X,Y<I*!2IF*$@?W_F=#M!,Q$(O].0L'J*3D[T!C>5G3_);(]
M#R@P#IEU.4RDCY<4[LPW GY&H$Y7$H.604YG,L$;1[!.$7U@F(8C%.(@_5$X
MC$P8@^,.IQBS/!,@(1D-(B_!W;GTNCE,2\,,AXJ/]>Q.4" 6Z,:[6FC74Q%;
MH@D6PB8A^')BS)!N$H4V\'Z?]V6 #X Q(=ZV FP>,YUX,(1^)K!.TZW2%3N#
M) @873*8!H@3JM@'U1(<@E>)^]_^*@E2P6JJFK3Q"X!XD*A0ZA%J!&+ID>S+
MF'4Z50=%2Y"YERB%C=,;<*"SK*YU&427"DY>R@)'7LHPOP"4@CZ>92_0=C,T
MVWGJ8($/6[-S G-LXW',/>3G2"@11]N8W 5Y(;KH"^8+X+R?V8V!#(2?6@U:
M\X %(/ 29%5S+- NF?7801'R,=F*G?RP[36 $=#=_A^8'2.9"A9(H^'2C!2/
M>,RT&6X'*%4IS;)(\NS *WP 7)5?A+F^;"]-\<S3)6X\,:&[6,0-*2Z6/HL8
MIP\J"AVG5[1XA1% 'K#Z &6EA='5Y?KU^QXF^R/1L1Q,C8L%O B27:6+?>Y=
M KJ$*5JI6@[HW][#6[@E-TM*FNEA$]R/!@M\H'7DR=FEQX<W("60V <('2,-
MA@T8+Z](!H^[/!_=MB_Z7X3UC(1'MBOW22(<<?*UJ5,"S2&WL$,JF;IF6%G]
M0'K!M.";T>R;]8_JC3V9DYTP!5H1P-AK4%.Z+1:'I"-![#I2E_".AWD$/ZT=
M!T6G@P W$DL-D>;F/]!6@]48@TU.E)COR9@8G4R,11T4*45SX+3V8&&J(0_E
M7V2;0*XP.\''P"8D ]:Q<7TP.+Z+IDN&:/:Y?\4S\XX3G+F\M*LL%#D,_YJ.
MA=7C,0^F?\&;)\#:*$R\0$0QA ALZ[!WLLW.IR$,H*4&NAIM=X]-TINU#?N@
MHQ'(#*9,"1$:%X.;TQ$'L^J)A.)5]IF'R0!0$U@'H+Z?:)"VUBN6\5U*^$IT
M]Z*@>6#FP+1JXZGYE"0#,H#5&EM&X^BKO@C% /D)L@5%X923RC62;.BU */,
MEWHR=RK@,"&Z#F,I*1X@,Q'S&Q .V(X=6#-!%F.B A;7A\)S&N;46YCUM:S7
M?W>K'0;\"C"F9\59<E! /"P8T^J1.N^#QNP+&F (^FQT'X>&9LK/0UP8BZ)L
MBE*YQ% 51E4@&^8;M:%8#JL13!IN?OPBEU<M4>!JG_P@9N!B6 ZYRJ;^[!R\
MDL##;7F$O7Z/X UH)]Y[-LPL7;R*D1&Z_$3A*<AB_,#3@Y*D'!!JCB>$_(KG
M)@,Q)"SS9R(5603"$WQVMJYX_X<VP 2- [R4:_&8@]PEEF_FY=L@L8&*QB8[
M"]Y[3,KF2^T%$29<>1\0S=NU*4<A'NZ3)DB#]3WAF>^099T@;M\%.IKW)=$,
MO?>GQ$[C3.C$6G@%G#98(<Q!HB^N1!!-Z.L,;NT4UBLT^5F25>(3\@"IC*%C
MVM7F\<*XJ&OH203W4W, QH[*BU -9@;K&H)+8?G1=:A3]1.QR3EDG $52C5[
MWCS@UI^)WX$^C,5)#V'<%!"3U4MU*G/(,2+U(4NA.!]C#I_.5=(>@VD$!FX2
MX1W^B"F+Y-%\TS4&@03.@Y;3/%ED'!$%X/@\NPV_!/0B#0!P!UX4W&U*E8_;
MMEFH3.2"2,'LCK/U G/>,"A\Q9'S[A-E*%93L7+P9^=-=FB('8$>2D4V^FLT
M8[T:/*5/*X+Y&:0T\'2&H];@^<+B,@=U"W 7H3R8GR+JW12"/J$WH1Z[$N)[
MZ97@(,S^FBO?^A1%EVCWZ/8,THP7/],[-.-V8:=I'YTG95(^!(8/67I&Y^P@
MZ)G&L #OC!,U+N-4R2OT((5$R"?X+SW#?28(..6ID4[3A%\88>%/_/A(%\R7
M#VF@' GV12#%('5TLY"+/L,;<SFLW,GQ*RZ#S,O-.JVRC_/S*T[,A'!B!Q":
MH0H])2:L"4=$.\6V"H(\ QAB6GKI;GD.8]:@6I46".6K*\\E[U'[67 Y0^,Y
M'.I/TPW\+*H'*5"@OT>\6#6>"6?3.&.>YLR_#XS')(R4]S-[F**$N4/XB^-7
MV9?03_!)(#$.8WH4)8&?9?T ,WM&NB9D&*P7 ?AKGI8@8,1P%057@EV&$%,0
M:4EH_H;X^1*B*DQD4$Q&JD;Z0& 0L7:D=*Y>E#O1& AXH&?P8E],HS4<P_6@
MHB#E!,>L.4ZE$(5S",M!A].0/=VSJ+*C@AY"+ XJ-$=&N6Z P!!9-D#ON !2
M<Q+_8X)$Z&-A/3NV]1^*IPH_"598BSBE/',ZNWH.R\5HZ9\?]O(]'/CZ,P1M
MC5GR*8,WLWRGQVDE9I;C#(3"/IHY[V1V@Z^?AI&50;.4[\2YZ"7Z#WM+4#?-
MFQ+VX7*LJ?Z$UB E POW1F!%"^WIW*EZQ=1LBMUHQ07\NE2UW/>][N][W;C7
MW:G:SAO;ZY[M:.=!46I+:.-'WV=[^S64YCQOF4T14;BM)]@>7'/MEK_]C-=^
MW79[SI+:/;'%;54[S8VNJ0'3T"AG&>]7!ENO;U9<>X<9=YT'.6/Z@)9N<[!T
MYV]?F:KS="?[.*K>PX1_W77Q+Y4''X3VE)S,W5']-?=Y?\UMN,]1&(O5# ^K
M!(_"FEN3E.M9-Q@\&NMN,]WO^,IB4F%T;N_9"63FYU!YI^,0R$B+BOY(@BG^
M/JY;KX[B,5TA4:@X\BE)]J[&W\KTJ.[@#<W'?4-SL=_07#"W\(:F0UOF?#&\
M?RT14DFWZ-B-)PN-LJVVES3_'I8-LU/ A>P((27WZ&+H#SSFC'X/8<L4)&$K
M1(\,?VN=Q7RH*:.,)1:^G^:WTKR8 22FH9_^)N+F]P>5WMA_#4B\_"$9O'/\
M1<#W<@=BG@/1GQ_]<GQP\>7L\,Z[J9=4Z0EKDXG4XJ^MFBV'0C%-V7+@%8<=
M?8QL:(?!-[N@)NF<E4>!B,P^A:2MB!$/!MFF"WF#M 'NAR8AO$/=\20>10HK
MNVXIOGDIC,6?6.VRY5],?:XK?YO5NNMLDDMIM*I-9[-DRFW=[E9;[L/_"""8
ME4;S07/B:QWK[D.<:GX^K5UMN7HG'PY_/SK?84?'O57G<%.F+7@VITD$/UB$
MLFG3KQ7I@QQ4?VF&Z.=I=X4@7W]\7-,U=JZDXF-V-@5Z-KF?]+4D%$NR!"^V
MZ98 #6\F=?A=_LM7,)91@-<TJ=Y(BH&)H6;;H^;G@=378+>]N;JQ^F[A&W-M
M5OVV'XUY Y"OUH_\*?PWBL?!_O\#4$L#!!0    ( .J ]%9O"3$L:0(  &T'
M   1    8V1X<RTR,#(S,#<R,"YX<V3-55U/VS 4?>^O\/(\-TD#A$2T2 ,A
M3>H^U('&V^0X-ZU%8F>V0\._QW9CE18Z5FD/ZTN<>\^Y'\?WIA>7?5.C1Y"*
M"3X-XG$4(.!4E(POI\'=[0T^#RYGH]'%!XSO/RWFZ%K0K@&NT94$HJ%$:Z97
M2*\ _13R@3T2]+TFNA*RP7CF:%>B?9)LN=)H$DT2#_->F<>T2$D64URD<(9/
MXC+!YR=G,29)-:E(D=$L23\N\ZB*HS0VB(*<IO@D,@1R6B68G&=97*6GQGOF
M@O8J5W0%#4&F-:[R7DV#E=9M'H;K]7J\3L9"+L-)%,7A_9?Y#P<-!FS-^,,.
MNB]D[?%):-T%4>#AM-P+;H2#GBGS;$+;;91.C*!$:\F*3L.-D>4:*M+5>AIT
M_'=':E8Q*(WF-5A5=P OW)K()>BOI '5$@KOYYR-$+)*L*854B/^)G.0(LZR
M+.QM;P':*#<7E&@W$ >E<'ALCSB>X"0>]ZH,PK]*NQN(<:4)IW!,;O.&/>]?
MU+"]U^-J\+SC:W#!%-#Q4CR&)3!W<V^G5X?@]H#M83<GX5QHQ[>6P=:VC%=B
M8S F6WCNJU] Y5?EU?R_,2+ND1-)I:C?F:>PE:(%J1FHE[OC JPD5-/ ;A#V
M4_NK)L785.(AKQ+L7H%UAX8"]7S;B>?JI]9PE;F &C;:_,^-MQ*.;=Q0E/EB
MN(L^LG_+OS5^Q,II<"7,US] UG:W^'SPR^)R;K ^F ]70L4X<P,7N5^,\/9_
M B/'N@CWL7M1.@7E-SYSY_W>!O( ^0.1DIIV]?&\;5D':8/1:S?L5KB[7)OW
M%POH#)NMGHV> 5!+ P04    " #J@/16?C/7C74*  !&7@  %0   &-D>',M
M,C R,S W,C!?;&%B+GAM;-5<76_;.!9][Z_09E]V@6$LBJ0H%6T&W4R["#;3
M!DV*&>QB8?#3$6I+@:PTR;]?2K83.Y9L4K)5[4OBCZO+<X]U+N\E:;_[]7$V
M]7ZH?)YDZ?L3>.J?>"H5F4S2R?N3;S>?0'3RZ]F;-^_^ L"?__AZZ?V6B?N9
M2@OO/%>L4-)[2(I;K[A5WA]9_CWYP;RK*2MTEL\ .*LN.\_NGO)D<EMX@1^@
ME=GJW?PM%)RR& K J0H!AA*!"(<0,*0#S7@L8D1_F;SU-?0I-!:<$0JP;RY@
M1"/ HCB&FA+S;E@YG2;I][?E'\[FRC/AI?/JZ?N3VZ*X>SL:/3P\G#[R?'J:
MY9-1X/MHM+(^69H_;MD_H,H:QG$\JMY]-ITG=8;&+1S]^?OEM;A5,P:2=%ZP
M5)0#S).W\^K%RTRPHF)]+RZOT:)\!E9FH'P)P  @>/HXER=G;SQO04>>3=57
MI;WR_[>O%XU#QJ/28I2J2?G97JD\R>1UP?+BDG$U->@K;\73G7I_,D]F=U.U
M>NTV5[K>[33/-[R6*.,2)0Q+E']M&FS4 ?Z!\!;;6 \ K@KW\Z$P[N+T\\'@
MWI@,H8X/>&V8SI 7-]3'5/9U[SX/U1GZ\1$?ZK;("C;MX;9X&68-\K1\X=(\
M6@Y3.MJ13*MQEJE[#:IZ+%0JU2);;KCV$OG^Q#P:2Y6,KY6XSY/BZ>.CN&7I
M1'UF,S7FE(<X(@@0""7 #)FI"\H(*)^%2G,80H3&Q?,]/58I^':]&KX:8_<
M)PZ1%0T*S=4\N\_%R]PVF]9-6&:N*F>W:)2:<>=W;'F!05D6 @O@9RN,W@JD
M5Z)\-WJ)IP6)TZ-3,QT4*YG80#(MRX L?QUZ)O:&_B*KN4%=Q3U7XG22_1B9
M2T=EM54^ .6#2DV-#D=;']N'?(62Y6(/QTN+D<A,A7-7@ VZ=9[-[,(I,KM/
M?$&;&?3$RW*I<E.UU@10>]_!@-\DQ=0(EV!(8$0!P3$"F! ?Q-0\53&2@OHZ
MQ$'D*MR5\Z&)M@+E9=J#P=_XW[T57'?5/K-GK]@VG!Q9K:YTM)+KZ[@[2?79
M6>\R?1U&G42W;-SE^8?Q8R;A\VPVNT^315<T'Y.(13SF ="FO3-]H6 @(D0
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MB^YC6IBZ^"(567Z7Y=7$>EVP0IUG]VF1/YUG4HTU#"/,( 5<4@6PYAC$<2P
MX]0/E,8!$=)6BA;C#4V@"\C>!N9?O JUH=E;(O=*Z/;JM>%]OZ8/S.:1E7X(
M(IW2@ ,]K9*#C?_>4H9#L.N)Q.6RMNGE@Y3F/II7?K_D5WGV(S'AC*F,./.9
M!DII4W3[IMYFC!. HYC0R/<%#:%;7JD?:* )90EV30$KP*YII(%?V_S1G;5^
M$D<+PEJDB]UL=,@3#8Y[3A"[P]O.#'OLW5/"5:[*/EX9+^79C(OY_%[E-^6V
M5OY%:]-2!C$/,*0!$(A%)AEH4_E+TY4+K$W9H2-%E'6YL6^PH:4&@Q>(-<#>
M K&W@.Q5F.VSPUZJ]V>(0Q)XY"S1B3NG1&%+2JMDL==Y;PG#-LSUI&%]C7OB
M6)WF>C[ \)M)26,_8E)"J8#T PVP\!G@(6= ".Q'6$FB=6B;+6I'&%J*>#[4
MMD#I&9A>B=,^+=03N3\7=*;GR G F1DGT>^,OI72ZSWV)N^= :UK>K>ANY#/
MLQ\J_\#G1<Y$,0Z1I(R;Z5Y%3 %,F0"1@!)(@GP(?1XJ:CW=;W@>FG K<-X=
MFZA3>ZUN<K5?HZT9.+(V%\'_9X7LOX?19&VTK;2XZ:DW#=8&L*Z]>H.VC?C'
MF<HG23KY9YX]%+=FHKYCZ=,XE+&44H0 "1:;@EL*P"##0&H4<U]+Q /EUH?7
MCC,T/2Z[RA56;P'66Z)U[<'KJ;5MP3L3UD\'[LI5B_9[)Q,=NN]ZOSTWWSN#
MV^Z]=YMW;KW7.T&(:!@$$@$A ]-TQPR".*+F3T@A$@I!S:T/F34/,[04L-4R
M'J3/[M1A_Y_TUD=OJH_43@^AD79KH0_3/%]GTT0DA4DFOYOB/4_8=.PS% C.
M8T!%& *L)0.,01]H0D)-( YYQ*W/E6ZY'YK47Q!Z*X@.ITJWV=LO[&Z<'%G0
M+G2XG2IMC+K=N=)M=_V=+&T,9>-L:;-5B]:X7''/%:OV?R/.)>$Q!1I+(] P
ME" N'PD:"D$Y%'%L?2AMW?'0I'E>;>X8<(Y[Z!MD6;3&+2DX=F=L%[U;7UP3
M:KNV>-U1?UUQ#?R-IKCN_8Z;TU?9O&#3?R=WU=V$8*R1" A0PA3!."A/NU _
M H@0@J5D(1;6Y[F;AQF:$%_OLR[ >@9MJ],MM<S:=L1=^>JG(7:FJOV&="T3
MW;>C-]W^G,WHVM :MZ+KK=OO)]V82\<J)$0CQ '$Y:9S^<7^.,0^P"3 . Q\
MA(7U7+ON>&@2?]XC*<&Y;QE57-GO%+DRT-<&T<[@6^T*K4?::3.H<M3['M Z
M_+JMGXWWW:7VP?B0I9]/4S89*TT1D2@$"",$,$4^,'UG""3"*D:14"H0MEK;
M\#PTL3V#\TIT]FK;I&N_W%J3<&2]6<;O)+C:6%LI;M-3;Y*K#6!=<_4&;<O;
M<^,H9].+5*K'?ZFG,0\YTMRG@,743'2(<!"7\YY ,O1]*"(267^OHG:$H8EP
M6:DM47H53,_@=*UF7Q-I6\AVH*>?&M:>F1;%:T/T'>K6UQY[+ED; MJN5IL,
MVPKY4S)=?>D.(JF09,04J\ITITAPP% 4  5]C*"F(D36$^AKYP.5;PG0^=N*
M6\39:K8='?W(U8:)%D+=#KF#1M><]2S/[3"VE5ECTW'QJ%R0^I+?9 _I6'&#
MFT41H$*8XI8;6<8:,H @BZ.(^IC2=E]J>!ECH!)]7@NI5C2SW"NQMEPS6B/4
M<<&H'4T]KQ99,=1^J6B;@^[K1&L^?\XBT790C2M$-:9M!7[#'B^DF<D3O?S9
M@>5,HDE(N%$W0)Q)@!75(-(X %Q@$DD9"4:QF\P;1AJHV U:;Q-NR]FYB6!;
MV1^ MG[$[\Y8BP2PAXT.::#)<\_)8$^ VREAWP4=9_[EO\LD57", D$# 0G@
M/HY-78X4B'PD@/ I#H,PCF/F6)?7C#+0A/ \MRT?>"58[TO:=M=H@UC'&J M
M73U7 =9,M:\$ZICH7@ML>/TYU4!=8(WU0*UQ6^%_59.D/(Z=%M4O0H:"0,DP
M,C-_N9Y&"011Z#.C?BTE] ,21=8;1W4##%3N+R =?U:SED1;?;>GIA]IV[+2
M0M#UH7?0\BN'/<NX/IQM!3?8-8EWG7$C]^]G;U:O)(N?'3][\S]02P,$%
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M 5!+ 0(4 Q0    ( .J ]%9+231$?QH  &U_   >              "  0
M  !A.3DQ<')E<W-R96QE87-E:G5L>3(P,C R,RYH=&U02P$"% ,4    " #J
M@/16+&W(@&,6   )CP  $0              @ &[&@  8V1X<RTR,#(S,#<R
M,"YH=&U02P$"% ,4    " #J@/16;PDQ+&D"  !M!P  $0
M@ %-,0  8V1X<RTR,#(S,#<R,"YX<V102P$"% ,4    " #J@/16?C/7C74*
M  !&7@  %0              @ 'E,P  8V1X<RTR,#(S,#<R,%]L86(N>&UL
M4$L! A0#%     @ ZH#T5K2%B4FP!@  W#   !4              ( !C3X
L &-D>',M,C R,S W,C!?<')E+GAM;%!+!08     !0 % % !  !P10     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
